130 related articles for article (PubMed ID: 37084559)
1. A novel caffeic acid derivative prevents angiotensin II-induced cardiac remodeling.
Lee SY; Kuo YH; Du CX; Huang CW; Ku HC
Biomed Pharmacother; 2023 Jun; 162():114709. PubMed ID: 37084559
[TBL] [Abstract][Full Text] [Related]
2. A novel caffeic acid derivative prevents renal remodeling after ischemia/reperfusion injury.
Huang CW; Lee SY; Wei TT; Kuo YH; Wu ST; Ku HC
Biomed Pharmacother; 2021 Oct; 142():112028. PubMed ID: 34399201
[TBL] [Abstract][Full Text] [Related]
3. Caffeic acid ethanolamide induces antifibrosis, anti-inflammatory, and antioxidant effects protects against bleomycin-induced pulmonary fibrosis.
Huang CW; Lee SY; Du CX; Wu ST; Kuo YH; Ku HC
Biomed Pharmacother; 2024 Apr; 173():116298. PubMed ID: 38394850
[TBL] [Abstract][Full Text] [Related]
4. Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-β signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis.
Wong CKS; Falkenham A; Myers T; Légaré JF
J Renin Angiotensin Aldosterone Syst; 2018; 19(1):1470320318759358. PubMed ID: 29575960
[TBL] [Abstract][Full Text] [Related]
5. Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo.
Samuel CS; Unemori EN; Mookerjee I; Bathgate RA; Layfield SL; Mak J; Tregear GW; Du XJ
Endocrinology; 2004 Sep; 145(9):4125-33. PubMed ID: 15155573
[TBL] [Abstract][Full Text] [Related]
6. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
[TBL] [Abstract][Full Text] [Related]
7. Human Endomyocardial Biopsy Specimen-Derived Stromal Cells Modulate Angiotensin II-Induced Cardiac Remodeling.
Miteva K; Van Linthout S; Pappritz K; Müller I; Spillmann F; Haag M; Stachelscheid H; Ringe J; Sittinger M; Tschöpe C
Stem Cells Transl Med; 2016 Dec; 5(12):1707-1718. PubMed ID: 27460853
[TBL] [Abstract][Full Text] [Related]
8. Dual Blockade of TGF-β Receptor and Endothelin Receptor Synergistically Inhibits Angiotensin II-Induced Myofibroblast Differentiation: Role of AT
Duangrat R; Parichatikanond W; Mangmool S
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108136
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.
Zhang R; Zhang YY; Huang XR; Wu Y; Chung AC; Wu EX; Szalai AJ; Wong BC; Lau CP; Lan HY
Hypertension; 2010 Apr; 55(4):953-60. PubMed ID: 20157054
[TBL] [Abstract][Full Text] [Related]
10. Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF β/Smad activation and cardiac fibrosis induced by angiotensin II.
Ma F; Li Y; Jia L; Han Y; Cheng J; Li H; Qi Y; Du J
PLoS One; 2012; 7(5):e35144. PubMed ID: 22574112
[TBL] [Abstract][Full Text] [Related]
11. Collagen receptor cross-talk determines α-smooth muscle actin-dependent collagen gene expression in angiotensin II-stimulated cardiac fibroblasts.
V H; Titus AS; Cowling RT; Kailasam S
J Biol Chem; 2019 Dec; 294(51):19723-19739. PubMed ID: 31699892
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II upregulates fibroblast-myofibroblast transition through Cx43-dependent CaMKII and TGF-β1 signaling in neonatal rat cardiac fibroblasts.
Cao L; Chen Y; Lu L; Liu Y; Wang Y; Fan J; Yin Y
Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):843-852. PubMed ID: 30060053
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7.
He X; Gao X; Peng L; Wang S; Zhu Y; Ma H; Lin J; Duan DD
Circ Res; 2011 Jan; 108(2):164-75. PubMed ID: 21127293
[TBL] [Abstract][Full Text] [Related]
14. A-kinase anchoring protein-Lbc promotes pro-fibrotic signaling in cardiac fibroblasts.
Cavin S; Maric D; Diviani D
Biochim Biophys Acta; 2014 Feb; 1843(2):335-45. PubMed ID: 24269843
[TBL] [Abstract][Full Text] [Related]
15. Caffeic acid ethanolamide prevents cardiac dysfunction through sirtuin dependent cardiac bioenergetics preservation.
Lee SY; Ku HC; Kuo YH; Yang KC; Tu PC; Chiu HL; Su MJ
J Biomed Sci; 2015 Sep; 22(1):80. PubMed ID: 26391855
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia regulates basal and induced DNA synthesis and collagen type I production in human cardiac fibroblasts: effects of transforming growth factor-beta1, thyroid hormone, angiotensin II and basic fibroblast growth factor.
Agocha A; Lee HW; Eghbali-Webb M
J Mol Cell Cardiol; 1997 Aug; 29(8):2233-44. PubMed ID: 9281454
[TBL] [Abstract][Full Text] [Related]
17. Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters.
Taniyama Y; Morishita R; Nakagami H; Moriguchi A; Sakonjo H; Shokei-Kim ; Matsumoto K; Nakamura T; Higaki J; Ogihara T
Circulation; 2000 Jul; 102(2):246-52. PubMed ID: 10889138
[TBL] [Abstract][Full Text] [Related]
18. Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1.
Ma J; Ma SY; Ding CH
Chin J Integr Med; 2017 May; 23(5):362-369. PubMed ID: 26956464
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits angiotensin II-induced differentiation of cardiac fibroblasts into myofibroblasts.
Bai J; Zhang N; Hua Y; Wang B; Ling L; Ferro A; Xu B
PLoS One; 2013; 8(9):e72120. PubMed ID: 24023727
[TBL] [Abstract][Full Text] [Related]
20. Androgen attenuates cardiac fibroblasts activations through modulations of transforming growth factor-β and angiotensin II signaling.
Chung CC; Hsu RC; Kao YH; Liou JP; Lu YY; Chen YJ
Int J Cardiol; 2014 Sep; 176(2):386-93. PubMed ID: 25125004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
